Ilex Medical Ltd (ILX.TA)
ILA 6326.0
(0.57%)
ILA 6326.0
(0.57%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -100.11 Million ILS | 32.99% |
| 2022 | -149.4 Million ILS | 25.48% |
| 2021 | -200.49 Million ILS | -115.39% |
| 2020 | -93.08 Million ILS | -300.29% |
| 2019 | 46.47 Million ILS | 221.54% |
| 2018 | 14.45 Million ILS | -36.71% |
| 2017 | 22.83 Million ILS | -58.93% |
| 2016 | 55.61 Million ILS | 30.09% |
| 2015 | 42.74 Million ILS | -36.96% |
| 2014 | 67.81 Million ILS | -48.23% |
| 2013 | 130.98 Million ILS | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -123.01 Million ILS | -22.87% |
| 2024 Q2 | -140.63 Million ILS | -14.32% |
| 2023 Q1 | -112.26 Million ILS | 24.86% |
| 2023 FY | -100.11 Million ILS | 32.99% |
| 2023 Q3 | -45.88 Million ILS | 73.33% |
| 2023 Q4 | -100.11 Million ILS | -118.21% |
| 2023 Q2 | -172.02 Million ILS | -53.23% |
| 2022 Q3 | -135.25 Million ILS | -1.44% |
| 2022 Q4 | -149.4 Million ILS | -10.46% |
| 2022 FY | -149.4 Million ILS | 25.48% |
| 2022 Q1 | -129.77 Million ILS | 35.28% |
| 2022 Q2 | -133.33 Million ILS | -2.74% |
| 2021 Q2 | -47 Million ILS | 51.15% |
| 2021 Q1 | -96.22 Million ILS | -3.37% |
| 2021 FY | -200.49 Million ILS | -115.39% |
| 2021 Q4 | -200.49 Million ILS | -87.13% |
| 2021 Q3 | -107.14 Million ILS | -127.95% |
| 2020 Q1 | 44.87 Million ILS | -3.44% |
| 2020 FY | -93.08 Million ILS | -300.29% |
| 2020 Q4 | -93.08 Million ILS | -747.31% |
| 2020 Q3 | -10.98 Million ILS | 29.89% |
| 2020 Q2 | -15.66 Million ILS | -134.92% |
| 2019 FY | 46.47 Million ILS | 221.54% |
| 2019 Q4 | 46.47 Million ILS | -3.46% |
| 2019 Q2 | 61.31 Million ILS | 192.2% |
| 2019 Q1 | 20.98 Million ILS | 45.18% |
| 2019 Q3 | 48.14 Million ILS | -21.49% |
| 2018 FY | 14.45 Million ILS | -36.71% |
| 2018 Q1 | 15.75 Million ILS | -31.03% |
| 2018 Q2 | 30.51 Million ILS | 93.71% |
| 2018 Q3 | 20.62 Million ILS | -32.39% |
| 2018 Q4 | 14.45 Million ILS | -29.93% |
| 2017 Q1 | 44.84 Million ILS | -19.37% |
| 2017 Q2 | 25.3 Million ILS | -43.56% |
| 2017 Q3 | 51.91 Million ILS | 105.12% |
| 2017 Q4 | 22.83 Million ILS | -56.01% |
| 2017 FY | 22.83 Million ILS | -58.93% |
| 2016 Q2 | 65.84 Million ILS | 117.19% |
| 2016 Q4 | 55.61 Million ILS | 12.23% |
| 2016 FY | 55.61 Million ILS | 30.09% |
| 2016 Q3 | 49.55 Million ILS | -24.74% |
| 2016 Q1 | 30.31 Million ILS | -29.08% |
| 2015 Q4 | 42.74 Million ILS | -11.8% |
| 2015 Q2 | 38.01 Million ILS | -18.27% |
| 2015 Q1 | 46.51 Million ILS | -31.4% |
| 2015 FY | 42.74 Million ILS | -36.96% |
| 2015 Q3 | 48.46 Million ILS | 27.48% |
| 2014 Q2 | 104.45 Million ILS | -9.71% |
| 2014 Q3 | 90.43 Million ILS | -13.42% |
| 2014 Q4 | 67.81 Million ILS | -25.01% |
| 2014 Q1 | 115.68 Million ILS | -11.68% |
| 2014 FY | 67.81 Million ILS | -48.23% |
| 2013 Q4 | 130.98 Million ILS | 1.47% |
| 2013 FY | 130.98 Million ILS | 0.0% |
| 2013 Q1 | 153.54 Million ILS | 0.0% |
| 2013 Q2 | 139.91 Million ILS | -8.88% |
| 2013 Q3 | 129.08 Million ILS | -7.74% |
| Name | Net Debt | Net Debt Difference |
|---|